These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36311296)
1. Class III obesity is an independent risk factor for unsuccessful induction of labor. Drummond R; Patel M; Myers M; Ritter A; Hurvitz JA; Goetzinger KR; Crimmins SD AJOG Glob Rep; 2022 Nov; 2(4):100109. PubMed ID: 36311296 [TBL] [Abstract][Full Text] [Related]
2. Nonmedically indicated induction in morbidly obese women is not associated with an increased risk of cesarean delivery. Kawakita T; Iqbal SN; Huang CC; Reddy UM Am J Obstet Gynecol; 2017 Oct; 217(4):451.e1-451.e8. PubMed ID: 28578171 [TBL] [Abstract][Full Text] [Related]
3. Mode of delivery in women with class III obesity: planned cesarean compared with induction of labor. Subramaniam A; Jauk VC; Goss AR; Alvarez MD; Reese C; Edwards RK Am J Obstet Gynecol; 2014 Dec; 211(6):700.e1-9. PubMed ID: 24956550 [TBL] [Abstract][Full Text] [Related]
4. Impacts of embracing 39-week elective induction across an entire labor and delivery unit. Jelks AT; Yao AQ; Byrne JD AJOG Glob Rep; 2023 May; 3(2):100168. PubMed ID: 36941864 [TBL] [Abstract][Full Text] [Related]
5. Maternal and newborn outcomes with elective induction of labor at term. Souter V; Painter I; Sitcov K; Caughey AB Am J Obstet Gynecol; 2019 Mar; 220(3):273.e1-273.e11. PubMed ID: 30716284 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term: a pilot randomized controlled trial. Pierce SL; Peck JD; Zornes C; Standerfer E; Edwards RK Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100681. PubMed ID: 35728781 [TBL] [Abstract][Full Text] [Related]
7. Institutional prevalence of class III obesity modifies risk of adverse obstetrical outcomes. Katz Eriksen JL; Souter VL; Napolitano PG; Chandrasekaran S Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100058. PubMed ID: 33345993 [TBL] [Abstract][Full Text] [Related]
8. Indications for primary cesarean delivery relative to body mass index. Kawakita T; Reddy UM; Landy HJ; Iqbal SN; Huang CC; Grantz KL Am J Obstet Gynecol; 2016 Oct; 215(4):515.e1-9. PubMed ID: 27210064 [TBL] [Abstract][Full Text] [Related]
9. Combination of Foley and prostaglandins versus Foley and oxytocin for cervical ripening: a network meta-analysis. Orr L; Reisinger-Kindle K; Roy A; Levine L; Connolly K; Visintainer P; Schoen CN Am J Obstet Gynecol; 2020 Nov; 223(5):743.e1-743.e17. PubMed ID: 32387325 [TBL] [Abstract][Full Text] [Related]
10. Favorable Simplified Bishop Score after cervical ripening associated with decreased cesarean birth rate. Lee DS; Tandel MD; Kwan L; Francoeur AA; Duong HL; Negi M Am J Obstet Gynecol MFM; 2022 Mar; 4(2):100534. PubMed ID: 34808400 [TBL] [Abstract][Full Text] [Related]
11. Induction of labor using one dose vs multiple doses of misoprostol: a randomized controlled trial. Pimentel VM; Arabkhazaeli M; Moon JY; Wang A; Kapedani A; Bernstein PS; Tropper PJ Am J Obstet Gynecol; 2018 Jun; 218(6):614.e1-614.e8. PubMed ID: 29614276 [TBL] [Abstract][Full Text] [Related]
12. Is vaginal misoprostol more effective than oral misoprostol for cervical ripening in obese women? Soni S; Pappas K; Lesser ML; Blitz MJ; Augustine SA; Rochelson B J Matern Fetal Neonatal Med; 2020 Oct; 33(20):3476-3483. PubMed ID: 30741048 [No Abstract] [Full Text] [Related]
13. Predicting obstetrical anal sphincter injuries in patients who undergo vaginal birth after cesarean delivery. Luchristt D; Brown O; Pidaparti M; Kenton K; Lewicky-Gaupp C; Miller ES Am J Obstet Gynecol; 2021 Aug; 225(2):173.e1-173.e8. PubMed ID: 33617798 [TBL] [Abstract][Full Text] [Related]
14. Intracervical Foley catheter with and without oxytocin for labor induction with Bishop score ≤3: a secondary analysis. Gagnon J; Corlin T; Berghella V; Hoffman MK; Sciscione A; Marie PS; Schoen CN Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100350. PubMed ID: 33757937 [TBL] [Abstract][Full Text] [Related]
15. Risk Factors Associated With Cesarean Delivery After Induction of Labor in Women With Class III Obesity. Paidas Teefey C; Reforma L; Koelper NC; Sammel MD; Srinivas SK; Levine LD; Durnwald CP Obstet Gynecol; 2020 Mar; 135(3):542-549. PubMed ID: 32028494 [TBL] [Abstract][Full Text] [Related]
16. Effects of maternal obesity on duration and outcomes of prostaglandin cervical ripening and labor induction. Pevzner L; Powers BL; Rayburn WF; Rumney P; Wing DA Obstet Gynecol; 2009 Dec; 114(6):1315-1321. PubMed ID: 19935035 [TBL] [Abstract][Full Text] [Related]
17. Oral or Vaginal Misoprostol for Labor Induction and Cesarean Delivery Risk. Handal-Orefice RC; Friedman AM; Chouinard SM; Eke AC; Feinberg B; Politch J; Iverson RE; Yarrington CD Obstet Gynecol; 2019 Jul; 134(1):10-16. PubMed ID: 31188317 [TBL] [Abstract][Full Text] [Related]
18. Buccal Versus Vaginal Misoprostol Combined with a Foley Catheter among Individuals with Obesity Undergoing Induction. Gomez Slagle HB; Kawakita T; Hoffman MK; Sciscione AC; Ma'ayeh M Am J Perinatol; 2024 May; ():. PubMed ID: 38631390 [TBL] [Abstract][Full Text] [Related]
19. Interdelivery weight gain and risk of cesarean delivery following a prior vaginal delivery. Dude AM; Lane-Cordova AD; Grobman WA Am J Obstet Gynecol; 2017 Sep; 217(3):373.e1-373.e6. PubMed ID: 28526451 [TBL] [Abstract][Full Text] [Related]
20. Buccal vs vaginal misoprostol combined with Foley catheter for cervical ripening at term (the BEGIN trial): a randomized controlled trial. Gomez HB; Hoffman MK; Caplan R; Ruhstaller K; Young MHH; Sciscione AC Am J Obstet Gynecol; 2021 May; 224(5):524.e1-524.e8. PubMed ID: 33617796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]